<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01893710</url>
  </required_header>
  <id_info>
    <org_study_id>Pediatric PD Biopsy Study</org_study_id>
    <secondary_id>University of Heidelberg</secondary_id>
    <nct_id>NCT01893710</nct_id>
  </id_info>
  <brief_title>International Pediatric Peritoneal Biopsy Study</brief_title>
  <official_title>International Pediatric Peritoneal Biopsy Study in Children on PD and Healthy Controls</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heidelberg University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Within few years the peritoneal membrane of adult peritoneal dialysis (PD) patients undergoes
      substantial morphological transformation, including progressive fibrosis, vasculopathy and
      neoangiogenesis. Ultrafiltration capacity steadily declines and ultimately results in PD
      failure. In children, peritoneal biopsies demonstrating PD associated alterations have not
      yet been obtained. They, however, should be particularly informative, since secondary tissue
      and vascular pathology related to ageing or diabetes is absent.

      An international, prospective peritoneal membrane biopsy study in children on PD will
      therefore be performed. Biopsies will be obtained at time of PD catheter insertion, on
      occasion of intercurrent abdominal surgery (e.g. hernia repair, catheter exchange) and at
      time of renal transplantation. Quantitative histomorphometry and tissue protein expression
      analyses will be correlated with time integrated PD treatment modalities and functional
      characteristics as well as inflammatory and cardiovascular comorbidity surrogate parameter.
      Blood will be obtained during clinical routine sampling. Biopsies will be obtained during
      clinically indicated operations, without substantially increasing operation time and
      associated surgical risks. The detailed histomorphometry of the PD membrane will give
      additional information, potentially impacting on the individual PD regime.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Please see study protocol and

      http://www.pedpd.org

      http://4c-study.org
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Semiquantitiave score of peritoneal vasculopathy (grade 0-5)</measure>
    <time_frame>Two years (Mean PD treatment time)</time_frame>
    <description>Children requiring peritoneal dialysis will undergo repeated biopsy sampling, i.e. at time of catheter insertion, intercurrent abdominal surgery and at time of renal transplantation, according to a standardized biopsy protocol. All samples will be transferred to the pediatric nephrology laboratory Heidelberg for central analyses.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of vessels per peritoneal membrane area (per mm²)</measure>
    <time_frame>at time of catheter insertion, intercurrent abdominal surgery and at time of renal transplantation</time_frame>
    <description>Quantitative histomorphometry will assess neoangiogenesis, i.e. the number of vessels per peritoneal membrane area, the major factor of peritoneal transport property and ultrafiltration capacity.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Submesothelial thickness (µm)</measure>
    <time_frame>2 years (average PD duration)</time_frame>
    <description>Further parameter of interst is submesothelial thickness as a marker of peritoneal fibrosis.</description>
  </other_outcome>
  <other_outcome>
    <measure>Leucocyte number (/mm²)</measure>
    <time_frame>2 years (mean PD duration)</time_frame>
    <description>Leucocyte infiltration is a parameter of PD induced membrane inflammation.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Chronic Renal Failure (CKD 5) and Peritoneal Dialysis</condition>
  <arm_group>
    <arm_group_label>Control, PD</arm_group_label>
    <description>'Biopsy sampling': Peritoneal biopsies from children without kidney disease, i.e. diseases not related to the kidney and not affecting the peritoneum, will be compared with biopsies from patients with chronic kidney disease, at time of catheter insertion, intercurrent abdominal surgery and at time of renal transplantation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>biopsy sampling</intervention_name>
    <description>Two parietal peritoneal samples, each 1 cm² x 0.3 cm in depth and three omental tissue samples, each 1 cm² in size will be obtained.
Biopsy sampling will be performed in all groups. This is an observational not an interventional trial.</description>
    <arm_group_label>Control, PD</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Parietal ond omental peritoneal membrane specimen will be collected in all groups
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        See below eligibility data
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 0 to 21 years. 0-70 years in patients with normal renal function

          -  CKD 5d, peritoneal dialysis and

          -  Patients with normal renal function and elective abdominal surgery due to limited
             pathology not affecting the Peritoneum, 0-70 years

          -  Oral and written consent

        Exclusion Criteria:

          -  Contraindications to peritoneal dialysis, such as severe abdominal adhesions,
             malformations and inflammations

          -  Pregnancy

          -  Preterm babies (below 37 weeks of gestational age)

          -  If serum hemoglobin &lt; 8 g/dl in children and &lt; 10 g/dl in newborns
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claus P Schmitt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Heidelberg, Center for Pediatric and Adolescent Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Claus P Schmitt, MD</last_name>
    <phone>+49 6221 56</phone>
    <phone_ext>39313</phone_ext>
    <email>claus.peter.schmitt@med.uni-heidelberg.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Children's Mercy Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bradley A. Warady, MD</last_name>
      <phone>816-234-3010</phone>
      <email>bwarady@cmh.edu</email>
    </contact>
    <investigator>
      <last_name>Bradley A. Warady, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Children´s Hospital of Philadelphia</name>
      <address>
        <city>Narberth</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Department of Pediatrics, Medical University Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klaus Arbeiter, MD</last_name>
      <phone>+43 1404003257</phone>
      <email>klaus.arbeiter@meduniwien.ac.at</email>
    </contact>
    <investigator>
      <last_name>Klaus Arbeiter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UZ Ghent</name>
      <address>
        <city>Ghent</city>
        <zip>9890</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johan Van de Walle, MD</last_name>
      <phone>+32 93322483</phone>
      <email>Johan.VandeWalle@uzgent.be</email>
    </contact>
    <investigator>
      <last_name>Johan Van de Walle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Children`s Hospital</name>
      <address>
        <city>Prague</city>
        <zip>15006</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Service de pédiatrie 2, Hôpital saint Jacques</name>
      <address>
        <city>Besancon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpital des Enfants</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Service de Néphrologie Pédiatrique, Hôpital Femme Mere Enfant</name>
      <address>
        <city>Lyon</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno Ranchin, MD</last_name>
      <phone>+33 427856129</phone>
      <email>bruno.ranchin@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Bruno Ranchin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Children`s Hospital</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel Fischbach, MD</last_name>
      <phone>+33 3127743</phone>
      <email>Michel.Fischbach@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Michel Fischbach, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Children`s Hospital</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Uwe Querfeld, MD</last_name>
      <phone>+49 30450516031</phone>
      <email>uwe.querfeld@charite.de</email>
    </contact>
    <investigator>
      <last_name>Uwe Querfeld, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Children`s Hospital</name>
      <address>
        <city>Cologne</city>
        <zip>50931</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Taylan, MD</last_name>
      <phone>+49 2214784391</phone>
      <email>christina.taylan@uk-koeln.de</email>
    </contact>
    <investigator>
      <last_name>Christina Taylan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Children`s Hospital</name>
      <address>
        <city>Essen</city>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>UKE, University Children´s Hospital</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Children`s Hospital</name>
      <address>
        <city>Budapest</city>
        <zip>1083</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Sallay, MD</last_name>
      <phone>+36 13343186</phone>
      <email>sallay.peter@med.semmelweis-univ.hu</email>
    </contact>
    <investigator>
      <last_name>Peter Sallay, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Children`Hospital</name>
      <address>
        <city>Genova</city>
        <zip>16147</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enrico Verrina, MD</last_name>
      <phone>+39 3475704081</phone>
      <email>enricoverrina@ospedale-gaslini.ge.it</email>
    </contact>
    <investigator>
      <last_name>Enrico Verrina, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Children`s Hospital</name>
      <address>
        <city>Milano</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Testa, MD</last_name>
      <phone>+39 0257992471</phone>
      <email>saratesta@tiscali.it</email>
    </contact>
    <investigator>
      <last_name>Sara Testa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pediatric Nephrology, Dialysis and Transplant Unit</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Rafik Hariri University Hospital</name>
      <address>
        <city>Beirut</city>
        <country>Lebanon</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University children`s Hospital</name>
      <address>
        <city>Vilnius</city>
        <zip>08406</zip>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rimante Cerkauskiene, MD</last_name>
      <phone>+37 052720427</phone>
      <email>rimantec@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Rimante Cerkauskiene, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Paediatric CAPD unit, Kuala Lumpur Hospital</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>50586</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Krakow, Jagiellonian University Medical College</name>
      <address>
        <city>Krakow</city>
        <zip>30663</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dorota Drozdz, MD</last_name>
      <phone>+48 12 658 11 59</phone>
      <email>dadrozdz@cm-uj.krakow.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Materno-Infantil Vall d' Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gema Ariceta, MD</last_name>
      <phone>+34 934893082</phone>
      <email>gariceta@vhebron.net</email>
    </contact>
    <investigator>
      <last_name>Gema Ariceta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>17176</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafael T Krmar, MD, PhD</last_name>
      <phone>+46 858581480</phone>
      <email>Rafael.Krmar@ki.se</email>
    </contact>
    <investigator>
      <last_name>Rafael T Krmar, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital, Inselspital, Bern University Hospital and University of Bern</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Children`s Hospital</name>
      <address>
        <city>Adana</city>
        <zip>01330</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aysun K Bayazit, MD</last_name>
      <phone>+90 3223386935</phone>
      <email>ayskar@cu.edu.tr</email>
    </contact>
    <investigator>
      <last_name>Aysun K Bayazit, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cerrahpasa School of Medicine</name>
      <address>
        <city>Istanbul</city>
        <zip>34303</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Salim Caliskan, MD</last_name>
      <phone>+90 5322121302</phone>
      <email>salimc@istanbul.edu.tr</email>
    </contact>
    <investigator>
      <last_name>Salim Caliskan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Czechia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Lebanon</country>
    <country>Lithuania</country>
    <country>Malaysia</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>Turkey</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <link>
    <url>http://4c-study.org</url>
    <description>Cardiovascular Comorbidity in Children with Chronic Kidney Disease</description>
  </link>
  <link>
    <url>http://www.pedpd.org</url>
    <description>International Pediatric Peritoneal Dialysis Network</description>
  </link>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2013</study_first_submitted>
  <study_first_submitted_qc>July 2, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 9, 2013</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heidelberg University</investigator_affiliation>
    <investigator_full_name>Claus Peter Schmitt</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>peritoneal dialysis</keyword>
  <keyword>parietal peritoneum</keyword>
  <keyword>omentum</keyword>
  <keyword>children</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

